Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis
Rohit Loomba, Vlad Ratziu, Stephen A. Harrison, Rohit Loomba, Stefanie C. McFarlane, Nobuharu Tamaki, Vlad Ratziu, Manal F. Abdelmalek, Mary E. Rinella, Quentin M. Anstee, Zobair M. Younossi, Arun J. Sanyal, Vipul Jairath, Stephen A. Harrison
Topics & Concepts
Nonalcoholic steatohepatitisMedicineDrugSteatohepatitisDrug developmentInternal medicinePharmacologyNonalcoholic fatty liver diseaseFatty liverDiseaseLiver Disease Diagnosis and TreatmentLiver Diseases and ImmunityDiet, Metabolism, and Disease